Search

Your search keyword '"Sperk Elena"' showing total 313 results

Search Constraints

Start Over You searched for: Author "Sperk Elena" Remove constraint Author: "Sperk Elena"
313 results on '"Sperk Elena"'

Search Results

3. L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial

4. Optimising inter-patient image registration for image-based data mining in breast radiotherapy

5. Concurrent gliomas in patients with multiple sclerosis

6. Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies

7. Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

8. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

11. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

12. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

13. Innovative radiation oncology Together – Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany

14. Optimising Inter-Patient Image Registration for Image-Based Data Mining in Breast Radiotherapy

15. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer : TARGIT-A randomised clinical trial

16. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer

18. Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer—Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).

20. CTNI-62. INTERIM DATA ON DUAL INHIBITION OF POST-RADIOGENIC ANGIO-VASCULOGENESIS BY OLAPTESED PEGOL (NOX-A12) AND BEVACIZUMAB IN GLIOBLASTOMA FROM THE FIRST EXPANSION ARM OF THE PHASE 1/2 GLORIA TRIAL

25. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

26. Correction to: Innovative radiation oncology Together—Precise, Personalized, Human

28. Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes

29. Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain Metastases

31. 2937: Dose deposition in sub-regions of breast relates to acute and persistent pain after radiotherapy

32. 1461: Prostate cancer patients with lower muscle mass have increased late toxicities post-radiotherapy.

33. 1378: Genetically-based analysis of dose surface maps for assessing toxicity post-RT: an innovative method

34. 1242: Sensitivity of dose-response mapping model parameters at the bladder and rectum in prostate cancer

35. 848: Treatment laterality and incidental dose to internal mammary nodes and axilla in breast radiotherapy

40. (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer.

41. Autoren

43. Supplementary Data from Association of CD4+ Radiation-Induced Lymphocyte Apoptosis with Fibrosis and Telangiectasia after Radiotherapy in 272 Breast Cancer Patients with >10-Year Follow-up

44. In Reply to Ward et al.

45. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

46. Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer".

50. Other Applications of INTRABEAM®

Catalog

Books, media, physical & digital resources